Home Featured Box Office: ‘No Time to Die’ Beating ‘F9’ Internationally

Box Office: ‘No Time to Die’ Beating ‘F9’ Internationally

by Paul Ebeling

#BoxOffice #Hollywood #international #Bond #F9 #movie #theater


No Time to Die has become the Top-grossing Hollywood movie of the VirusCasedemic era at the international box office after finishing Sunday with $558.2-M in ticket sales and besting the $549-M earned overseas by F9 .

Universal’s F9 , is also handling No Time Time Die internationally on behalf of MGM and EON Productions.

No Time to Die the 25th installment in the storied franchise and directed by Cary Fukunaga stars Daniel Craig in his final turn as 007.

Among other accomplishments, No Time To Die has surpassed Skyfalll ‘s lifetime gross in 18 markets and Spectre in another 22 markets, not adjusted for inflation.

In North America, the James Bond pic crossed the $150-M mark over the weekend to finish Sunday with a worldwide tally of $708.6-M

Sony’s Venom: Let There Be Carnage celebrated its own milestone over the weekend upon clearing $200-M in domestic ticket sales.

Venom 2 finished Sunday with a domestic total of $202.7-M and $441.5-M globally.

Have some fun, see a movie in a theater this week, the chaos is almost over, Keep the Faith!

You may also like


Your Trusted Source for Capital Markets & Related News

© 2023 LiveTradingNews.com – For The Traders, By The Traders – All Right Reserved.

The information contained on this website shall not be construed as (i) an offer to purchase or sell, or the solicitation of an offer to purchase or sell, any securities or services, (ii) investment, legal, business or tax advice or an offer to provide such advice, or (iii) a basis for making any investment decision. An offering may only be made upon a qualified investor’s receipt not via this website of formal materials from the Knightsbridge an offering memorandum and subscription documentation (“offering materials”). In the case of any inconsistency between the information on this website and any such offering materials, the offering materials shall control. Securities shall not be offered or sold in any jurisdiction in which such offer or sale would be unlawful unless the requirements of the applicable laws of such jurisdiction have been satisfied. Any decision to invest in securities must be based solely upon the information set forth in the applicable offering materials, which should be read carefully by qualified investors prior to investing. An investment with Knightsbridge is not suitable or desirable for all investors; investors may lose all or a portion of the capital invested. Investors may be required to bear the financial risks of an investment for an indefinite period of time. Qualified investors are urged to consult with their own legal, financial and tax advisors before making any investment. Knightsbridge is a private investment firm that offers investment services to Qualified Investors, Members and Institutions ONLY. Qualified Investors are defined as individuals who have met those Qualifications in the relevant jurisdictions. Members are defined as individuals who have been accepted into the Knightsbridge membership program. Institutions are defined as entities such as banks, pension funds, and hedge funds. If you are not a Qualified Investor, Member or Institution, you are not eligible to invest with Knightsbridge. All investments involve risk, and there is no guarantee of profit. You may lose some or all of your investment. Past performance is not indicative of future results. Knightsbridge is not a registered investment advisor, and this disclaimer should not be construed as investment advice. Please consult with a qualified financial advisor before making any investment decisions. By accessing this website, you agree to the terms of this disclaimer. Thank you for your interest in Knightsbridge.